针对癌症治疗的HSP90:目前的进展和新兴前景
Xinqi Liang1, Ruixian Chen1,2, Chengdi Wang1
1Department of Neurology, Laboratory of Neuro-system and Multimorbidity and Targeted Tracer Research and Development Laboratory and Institute of Respiratory Health and Frontiers Science Center for Disease-related Molecular Network and Department of General Surgery, West China Hospital, Sichuan University, Chengdu, 610041 Sichuan, China.
热冲击蛋白90 (HSP90) 是一个关键的癌症标. 新型HSP90抑制剂正在开发中,以克服早期药物的局限性,为癌症治疗提供新的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 热冲击蛋白90 (HSP90) 对于癌细胞的生存和增殖至关重要.
- HSP90调节了许多涉及瘤发生的蛋白质和信号通路.
- 传统的HSP90抑制剂在临床前表现有希望,但在临床有效性和毒性方面面临挑战.
研究的目的:
- 审查HSP90在癌症中的结构,功能和作用.
- 分析现有的HSP90抑制剂的临床进展.
- 突出开发下一代HSP90抑制剂的新策略.
主要方法:
- 文献审查和临床前和临床数据的分析.
- 对新兴抑制剂设计的药物化学方法的检查.
- 讨论新兴的策略,包括选择性,双重和蛋白质-蛋白质相互作用抑制剂,以及向蛋白质分解的嵌合体.
主要成果:
- 超过20种HSP90抑制剂已经进入临床试验,证明了抗瘤潜力.
- 现有的抑制剂在临床疗效和剂量限制性毒性方面存在局限性.
- 新的策略旨在提高选择性并减少非目标效应.
结论:
- HSP90仍然是瘤学中验证和有前途的治疗点.
- 先进的抑制剂设计对于克服临床挑战至关重要.
- 未来的研究重点是开发更有效,更安全的HSP90向癌症疗法.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Abnormal Proliferation
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
